Company intelligence / Profile preview

Amazu Biomimicry

Ownership: Private
Development stage: Other

Overview

Amazu Biomimicry is a Brazilian consultancy specializing in applying biomimicry principles to business innovation, sustainability strategies, organizational culture development, and leadership. The company does not develop drugs or medical products but provides services that help organizations innovate by learning from nature’s systems. Their BIOSPRINT methodology delivers rapid prototyping of solutions inspired by natural models.

Industry: Consulting

Partnerships

The American Biomimicry InstituteThe Biomimicry InstituteBiomimicry 3.8

Beyond the preview

Go deeper on Amazu Biomimicry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amazu Biomimicry.

Explore the full profile